23andMe

uBiome is jumping into therapeutics with a healthy $83 million in Series C financing

23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether you

Nutrigene wants to personalize your vitamins using your genetic code

Vitamins are proving to be a lucrative industry in the United States. Just last year vitamin sales pulled in roughly $37 billion for the U.S. economy. That’s up from $28 billion in 2010. To cas

23andMe might soon offer a more comprehensive $749 DNA service

23andMe is testing a $749 “premium” service for deeper health insights, according to several customers who saw a test page for the new product and posted about it on Reddit. First spotted

23andMe underscores that privacy-loving customers need to opt out of its data deal with GlaxoSmithKline

23andMe, the genetics testing company, is in a state of constant evolution, as you’d expect any 12-year-old company would be. But that also means that customers need to be aware of how the compa

George Church’s genetics on the blockchain startup just raised $4.3 million from Khosla

Nebula Genomics, the startup that wants to put your whole genome on the blockchain, has announced the raise of $4.3 million in Series A from Khosla Ventures and other leading tech VC’s such as 

23andMe’s ancestry tools are getting better for people of color

23andMe is beefing up its African, East Asian and Native American ancestry capabilities — something it has sorely lacked. Specifically, 23andMe has added 12 new regions across Africa and East As

The five best reasons you don’t want to miss Disrupt SF this September

TechCrunch’s Disrupt SF (Sept. 5-7) is our most ambitious event ever. And if we’re sure of one thing, it’s that people in the startup scene will extract more insights and inspiration

The erosion of Web 2.0

It seems quaint to imagine now but the original vision for the web was not an information superhighway. Instead, it was a newspaper that fed us only the news we wanted. This was the central thesis bro

Genoox raises $6M to help physicians better diagnose patients with genomic data

23andMe, Color, and other genomic sequencing startups have exposed demand from consumers for cheap ways to test for potential problems they may have — and Amir Trabelsi hopes to bring that mentalit

DNA analysis site that led to the Golden State Killer issues a privacy warning to users

As more details emerge about the arrest of the man suspected to be the Golden State Killer, it’s clear that one of the most infamous unsolved cases of all time was cracked using a popular free o

Genetics testing startup Prenetics buys UK’s DNAFit to move into consumer services

Prenetics, a Hong Kong-based startup that offers genetic testing services for patients, is expanding outside of Asia and into the consumer space after it acquired London-based company DNAFit. The deal

23andMe’s Anne Wojcicki and Unity’s John Riccitiello to join us at Disrupt SF 2018

Disrupt SF might feel familiar to many of you, but I encourage you to be prepared for a surprise. The world’s most impactful tech startup conference is about to get bigger and better than ever.

23andMe gets FDA green light for cancer risk test

Genetic testing powerhouse 23andMe announced today that it's officially received the FDA go-ahead to launch a direct-to-consumer testing kit for genes linked to various forms of cancer. The forthcomin

Helix holds first close on a planned $200 million investment in its genetic services marketplace

Welcome to the future… where startups are willing to customize everything from a diet regimen to a workout plan, or family planning to personal fashion based on an individual’s genetic c

Human sequencing pioneer George Church wants to give you the power to sell your DNA on the blockchain

The blockchain is the buzziest thing on the internet these days and now MIT professor and godfather of the Human Genome Project George Church wants to put your genes on it. His new startup Nebula Geno

Ancestry answered the DNA questions 23andMe couldn’t

A really awesome thing about being black is that ancestry can be very unclear because of, you know, slavery. Enter DNA kits.

23andMe confirms $250 million round led by Sequoia

Genetics testing company 23andMe has formally announced that Sequoia Capital is leading an investment round in the company. This confirms the news we broke last week.  The press release says that the

23andMe’s second act sits squarely in drug research and development

The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders f

Equity podcast: Roku is going public, 23andMe raises $200M and Juicero is dead

Hello and welcome back to Equity, TechCrunch’s venture capital-themed podcast. This week Matthew Lynley, Katie Roof, and myself — Alex! — sat down with Micah Rosenbloom, an investo

23andMe hits $1.5B pre-money valuation in latest huge funding round

Following up on the news of 23andMe’s huge upcoming financing round, TechCrunch has learned that the company is raising the new financing at a $1.5 billion pre-money valuation. This compares to
Load More